Jan 7 2021

Germany: CureVac and Bayer team up on COVID vaccine

German pharmaceutical giants CureVac and Bayer have teamed up on the development of a new COVID-19 vaccine candidate. The announcement was made by Bayer in a statement on Thursday.

Bayer’s Berlin premises was seen on Thursday morning just after the news was announced.

Bayer says it will support CureVac in the development and supply of its ‘CVnCoV’ COVID-19 vaccine candidate.

“The companies plan to combine their strengths for CureVac to be in a position to supply hundreds of millions of CVnCoV doses around the world, once approvals are granted,” Bayer wrote in its statement.


Written by admin

%d bloggers like this: